D-dimer level and outcome of minor ischemic stroke with large vessel occlusion

J Neurol Sci. 2020 Jun 15:413:116814. doi: 10.1016/j.jns.2020.116814. Epub 2020 Mar 31.

Abstract

Objective: To determine the predictors of unfavorable outcomes in acute minor ischemic stroke patients with large vessel occlusion.

Methods: The derivation cohort included ischemic stroke patients admitted to a comprehensive stroke center within 7 days after onset with large vessel occlusion and an initial National Institutes of Health Stroke Scale score of 5 or less. An unfavorable outcome was defined as dependency (modified Rankin Scale score of 3 to 6) at 3 months from the onset. The predictive values of factors related to an unfavorable outcome were evaluated. External validation was performed from a stroke registry of a tertiary medical center.

Results: In the derivation cohort, 3839 consecutive patients were screened; a total of 130 patients were included. Twenty-four (18%) patients had unfavorable outcomes. In multivariate analysis, D-dimer ≥1900 μg/l (odds ratio (OR) 3.31, 95% confidence interval (CI) 1.14-9.61, p = .028) and age (OR 2.01, 95% CI 1.05-3.86, p = .035) were independently associated with an unfavorable outcome. No significant differences were observed regarding occluded vessel sites. In the validation cohort, 850 consecutive patients were screened; a total of 74 patients were included. D-dimer ≥1900 μg/l (OR 8.78, 95% CI 1.41-54.61, p = .020) was the only factor independently associated with an unfavorable outcome, as in the derivation cohort.

Conclusions: A high D-dimer level on admission could help predict unfavorable outcomes in patients with a minor ischemic stroke with large vessel occlusion.

Keywords: D-dimer; Ischaemic stroke; Large vessel occlusion; Minor ischaemic stroke; Risk factor; Stroke.

MeSH terms

  • Brain Ischemia* / complications
  • Fibrin Fibrinogen Degradation Products
  • Humans
  • Ischemic Stroke*
  • Stroke* / diagnosis
  • Stroke* / therapy
  • Treatment Outcome

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D